| 2026-02-02 | Mr. Dennis TurpinCFO & Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 828,56k | 3,11% |
| 2025-12-18 | Dr. Louis FlamandMember of Scientific Advisory Board & Independent Director | 6,08k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 17,62k | 52,73% |
| 2025-12-18 | Mr. Dennis TurpinCFO & Director | 6,08k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 13,39k | 83,21% |
| 2025-12-18 | Ms. Kathryn J. GregoryIndependent Director | 6,08k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 12,04k | 102,19% |
| 2025-12-18 | Mr. David Charles BakerIndependent Director | 6,08k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 24,22k | 33,54% |
| 2025-12-18 | Mr. Edward DahlInsider | 15,21k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 21,16k | 255,48% |
| 2025-12-18 | Ms. Viktoria KrastevaInsider | 684,32 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 9,02k | 8,21% |
| 2019-05-12 | Dr. Andre P. BouletPresident, CEO, Chief Scientific Officer & Chair of the Board | -277,78 | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2019-05-12 | Ms. Colette LaurinInsider | -277,78 | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2025-06-09 | Mr. Dennis TurpinCFO & Director | 7,31k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 6,58 | 7,31k | - |